Khaled Seidi
Impact in
- Cancer Research top 5%
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 6
- Signaling Pathways in Disease 2
- Oncology 9
- Peptidase Inhibition and Analysis 3
- Co-authors
- Rana Jahanban‐Esfahlan (30 shared papers)Tahereh Javaheri (12 shared papers)Payman Zare (10 shared papers)Mehdi Jaymand (8 shared papers)Abbas Ebrahimi‐Kalan (2 shared papers)Roghayyeh Baghban (1 shared paper)Leila Roshangar (1 shared paper)Saeed Kolahian (1 shared paper)
- Journals
- Journal of Cellular Physiology (2 papers)Advanced Pharmaceutical Bulletin (2 papers)Journal of Controlled Release (2 papers)Advanced Functional Materials (2 papers)Nano Today (1 paper)
- Partner nations
- IranUnited StatesPoland
In The Last Decade
Khaled Seidi
36 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 524
- Biomaterials 447
- Molecular Medicine 148
- Oncology 734
- Immunology 553
Countries citing papers authored by Khaled Seidi
This map shows the geographic impact of Khaled Seidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Seidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Seidi more than expected).
Fields of papers citing papers by Khaled Seidi
This network shows the impact of papers produced by Khaled Seidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Seidi. The network helps show where Khaled Seidi may publish in the future.
Co-authors
The 25 scholars most cited alongside Khaled Seidi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor microenvironment complexity and therapeutic implications at a glance Hit paper breakdown → | 2020 | 1223 |
| 2 | 2018 | 124 | |
| 3 | 2020 | 118 | |
| 4 | 2017 | 113 | |
| 5 | 2017 | 99 | |
| 6 | 2020 | 98 | |
| 7 | 2019 | 86 | |
| 8 | 2018 | 81 | |
| 9 | 2017 | 76 | |
| 10 | 2017 | 72 | |
| 11 | 2021 | 60 | |
| 12 | 2023 | 46 | |
| 13 | 2017 | 45 | |
| 14 | 2019 | 44 | |
| 15 | 2019 | 44 | |
| 16 | 2018 | 44 | |
| 17 | 2021 | 43 | |
| 18 | 2019 | 38 | |
| 19 | 2019 | 37 | |
| 20 | 2017 | 33 |
About Khaled Seidi
Khaled Seidi is a scholar working on Molecular Biology, Oncology, Cancer Research, Biomaterials and Immunology, having authored 37 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Protease and Inhibitor Mechanisms (4 papers), Cancer Research and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers), Signaling Pathways in Disease (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Cancer Research (524 citations), Biomaterials (447 citations), Molecular Medicine (148 citations), Oncology (734 citations) and Immunology (553 citations). Khaled Seidi has collaborated with scholars based in Iran, United States and Poland. Frequent co-authors include Rana Jahanban‐Esfahlan, Tahereh Javaheri, Payman Zare, Mehdi Jaymand, Abbas Ebrahimi‐Kalan, Roghayyeh Baghban, Leila Roshangar, Saeed Kolahian, Nosratollah Zarghami and Ali Jahanban‐Esfahlan. Their work appears in journals such as Journal of Cellular Physiology, Advanced Pharmaceutical Bulletin, Journal of Controlled Release, Advanced Functional Materials and Nano Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.